Implementation of advanced therapy medicinal products: a UK pharmacist’s perspectivePublished: October 18, 2019
Advanced therapy medicinal products (ATMP) have introduced a new area of specialism to the clinical pharmacy workforce. The author will explore the role of the pharmacist in the UK in the delivery of cell-based medicines, emphasizing governance and clinical requirements, and recognizing that operationalizing ATMPs requires a collaborative multidisciplinary approach to ensure that the medicines are optimized for patients. This involves ensuring that whilst appropriate pharmacovigilance and pharmaceutical procedures are in place, handling is undertaken by a workforce that is trained and competent in the handling of cellular products.DOI: 10.18609/cgti.2019.130
Submitted for review: June 29, 2019
Citation: Cell & Gene Therapy Insights 2019; 5(10), 1237-1246.